'Hijacker' drives cancer in some patients with high-risk neuroblastoma

(St. Jude Children's Research Hospital) Researchers in Memphis and Boston have collaborated to show c-MYC is an oncogene that drives neuroblastoma in some high-risk patients; the findings help set the stage for much-needed precision medicines